| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. | CEO, Director | Stock Option (right to buy) | 450,000 | $4,050,000 | $9.00 | 09 Jan 2026 | Direct |
| TENAX THERAPEUTICS, INC. | CEO, Director | Common Stock | 2,605 | $23,445 | $9.00 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TENX | TENAX THERAPEUTICS, INC. | 09 Jan 2026 | 1 | $0 | 4 | CEO, Director | 13 Jan 2026, 21:37 |
| TENX | TENAX THERAPEUTICS, INC. | 18 Nov 2025 | 3 | +$20,000 | 4 | CEO, Director | 20 Nov 2025, 18:38 |
| TENX | TENAX THERAPEUTICS, INC. | 16 May 2025 | 1 | $0 | 4 | CEO, Director | 20 May 2025, 18:50 |
| TENX | TENAX THERAPEUTICS, INC. | 10 Dec 2024 | 1 | $0 | 4 | CEO, Director | 12 Dec 2024, 20:02 |
| TENX | TENAX THERAPEUTICS, INC. | 17 May 2024 | 1 | $0 | 4 | CEO, Director | 21 May 2024, 17:00 |
| TENX | TENAX THERAPEUTICS, INC. | 09 Jun 2022 | 1 | $0 | 4 | CEO, Director | 10 Jun 2022, 21:15 |
| TENX | TENAX THERAPEUTICS, INC. | 14 Jul 2021 | 0 | $0 | 3 | CEO, Director | 15 Jul 2021, 16:33 |